- Search results for 2070015-14-2
Cookie preferences
This website uses cookies, which are necessary for the technical operation of the website and are always set. Other cookies, which increase the comfort when using this website, are used for direct advertising or to facilitate interaction with other websites and social networks, are only set with your consent.
Configuration
Technically required
These cookies are necessary for the basic functions of the shop.
"Allow all cookies" cookie
"Decline all cookies" cookie
CSRF token
Cookie preferences
Currency change
Customer-specific caching
FACT-Finder tracking
Individual prices
Selected shop
Session
Comfort functions
These cookies are used to make the shopping experience even more appealing, for example for the recognition of the visitor.
Note
Show the facebook fanpage in the right blod sidebar
Statistics & Tracking
Affiliate program
Conversion and usertracking via Google Tag Manager
Track device being used
2 products were found matching "2070015-14-2"!
Close filters
Filter by:
No results were found for the filter!
Item number: TGM-T19198-10mg
Description: Atovaquone D4 is the deuterium-labeled Atovaquone. Atovaquone is a medication used to treat or prevent pneumocystis babesia, malaria, toxoplasmosis, and pneumonia. Smiles: O=C1C(=C(O)C(=O)C=2C1=C(C(=C(C2[2H])[2H])[2H])[2H])[C@H]3CC[C@@H](CC3)C4=CC=C(Cl)C=C4. References: Looareesuwan, S., et al.,...
Application: | GC-MS, LC-MS, internal standard, quantification, reversible MAO-B inhibitor |
CAS | 2070015-14-2 |
MW: | 370.86 D |
From 383.00€
*
Item number: Cay28491-1
Atovaquone-d4 is intended for use as an internal standard for the quantification of atovaquone (Cay-23802) by GC- or LC-MS. Atovaquone is a broad-spectrum antiprotozoal agent that is active against Plasmodium, Toxoplasma, and Babesia, among other protozoa. It inhibits complex III activity on dihydroorotate in...
Keywords: | 2-[trans-4-(4-chlorophenyl)cyclohexyl]-3-hydroxy-1,4-naphthalenedione-5,6,7,8-d4 |
Application: | GC-MS, LC-MS, Internal standard, Quantification, Reversible MAO-B inhibitor |
CAS | 2070015-14-2 |
MW: | 370.9 D |
731.00€
*